These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6903191)

  • 1. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation.
    Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH
    J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191
    [No Abstract]   [Full Text] [Related]  

  • 2. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Adv Exp Med Biol; 1983; 156():109-13. PubMed ID: 6552836
    [No Abstract]   [Full Text] [Related]  

  • 4. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
    Kerbiriou DM; Bouma BN; Griffin JH
    J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoelectrophoretic studies of prekallikrein in human plasma.
    Hathaway WE; Christian J; McGregor R; Borden C
    Thromb Res; 1982 Feb; 25(3):267-75. PubMed ID: 6917563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T; Dubin A; Moore W; Tanaka R; Travis J
    Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
    Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.
    Kalter ES; van Dijk WC; Timmerman A; Verhoef J; Bouma BN
    J Infect Dis; 1983 Oct; 148(4):682-91. PubMed ID: 6355312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material.
    Saito H; Goodnough LT; Soria J; Soria C; Aznar J; España F
    N Engl J Med; 1981 Oct; 305(16):910-4. PubMed ID: 6792540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion.
    Vicente V; Alberca I; Gonzalez R; Alegre A; Redondo C; Moro J
    Haematologia (Budap); 1986; 19(1):41-8. PubMed ID: 3636267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen.
    Scicli AG; Mindroiu T; Scicli G; Carretero OA
    J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
    Proud D; Pierce JV; Pisano JJ
    J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Amundsen E
    Haemostasis; 1978; 7(2-3):79-84. PubMed ID: 658781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic protein synthesis of the kallikrein-kininogen-kinin system].
    Adam A; Reynaert M; Damas P; Ers P; Boulanger J; Roeseler J; Faymonville ME; Lamy M; Damas J
    Presse Med; 1988 Feb; 17(4):151-4. PubMed ID: 2964610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
    Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
    J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of high molecular weight kininogen in contact activation.
    van Iwaarden F; Bouma BN
    Semin Thromb Hemost; 1987 Jan; 13(1):15-24. PubMed ID: 2436301
    [No Abstract]   [Full Text] [Related]  

  • 19. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T; McIntyre JA
    J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma contact activation: a revised hypothesis.
    Schmaier AH
    Biol Res; 1998; 31(3):251-62. PubMed ID: 9830513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.